Hormone Therapy

Developed to calculate individual risk estimates of prostate cancer-specific mortality, the AI-powered platform marks the first externally developed prostate digital pathology algorithm embedded for clinical use within the Tempus diagnostics ecosystem.

In this presentation, Dr. Urban Emmenegger explores the benefits and limitations of treatment intensification for prostate cancer, comparing hormone therapy alone with combination approaches such as androgen receptor inhibitors, chemotherapy, and other treatment strategies. It reviews the key factors that influence treatment decisions, including survival outcomes, quality of life, monitoring requirements, cost and insurance considerations, and individual patient preferences. The presentation also discusses how clinicians tailor treatment recommendations based on disease characteristics, such as tumor burden, symptoms, PSA levels, and imaging findings, alongside patient-specific factors including age, overall health, and personal values.

Androgen Deprivation Therapy (ADT) is an effective treatment for prostate cancer, but has many side effects. The ADT Educational Program is a free 1.5-hour session during which patients and loved ones will: Learn about the side effects of ADT, Learn how to manage side effects, and Complete goal setting exercises to teach you how to manage ADT side effects. The program is designed for both patients and their partners or loved ones. Patients who are not partnered are encouraged to invite a family member or close friend to attend the session.

ADT is associated with an increased risk of cognitive decline, a side effect not often discussed. Fortunately, there are strategies that you can use to maintain and regain cognitive function following ADT therapy. Read this article for practices you can implement to support your brain health.

This pamphlet explains: • How androgen deprivation therapy (ADT) affects your bones • What puts your bones at risk for fracture • How to strengthen your bones • What you can do to prevent osteoporosis

While similar, GnRH agonists and antagonists have different bodily targets that influence their effects on prostate cancer. This article explains the difference in function between these two classes of drugs, how and when one is used over the other, and the pros and cons of each.

LHRH agonists are a common hormone therapy drug prescribed for the treatment of prostate cancer. This article provides a detailed overview of how this drug works, what the typical treatment course looks like and answers some of the common questions regarding this treatment.

The growth of prostate cancer cells depends on testosterone. Hormone therapy works by lowering the testosterone in your body. When the testosterone is removed from the cancer cells, they will either die or slow down and stop growing. Hormone therapy alone is not a cure for prostate cancer.

This resource provides you with general information on Hormone therapy, types of hormone therapies, pros and cons, medical follow-up, side effects, suggestions and advice.